Improving Patient Experience and Outcomes Through Evidence-Based Regenerative Medicine

With Whom Do We Work?

  • Hospitals & Clinics

    New primary, adjunct therapies. New patient populations. Co-investment.

  • Industry

    Studies, peer-reviewed papers, focused workshops, new indications for existing products.

  • Scientists

    Accelerate publications, translational and innovative research.

  • Patients

    Authoritative regenerative medicine procedures. Transparent patient experience.

  • Government

    Practical, scientifically supported approaches to public sector and military needs.

  • Foundations

    Focused research/studies utilizing international thought-leader network.

  • Research Institutions

    Accelerate translation opportunities.  Participate in multi-center studies/trials.

  • Private Practices

    Increased revenues.  Build enduring equity value.

  • Veterinary

    Increased revenues through new science-based therapies.

Latest Regen Med Activities

  • CELLS | Musculoskeletal 2016: Post-Conference Resources

    CELLS | Musculoskeletal 2016: Post-Conference Resources

    We would like to thank those who attended our recent CELLS | Musculoskeletal 2016 conference. You came from over twenty countries and various specialties to experience a highly scientific, yet clinically-relevant program that was excellently delivered by the prestigious faculty. We hope it has furthered interests in regenerative medicine, introduced all to a strong international network and elucidated pathways for clinical translation. 

    On our new event website, a select number of speaker presentations have been made available for download for a one-time fee of $250. You are invited to review the available content prior to purchase, which include PDF versions of the delivered Powerpoints, and companion audio recordings of their live delivery. Presentation access is free for those who attended, please refer to our post-conference email for your username and password details.

    The event is but a stepping stone towards true translation. For those who wish to continue the dialogue, we further encourage reaching out to us directly at We would be happy to provide next steps towards the establishment of regenerative medicine capabilities at your home clinic, hospital or laboratory.

  • Bringing Cell Therapies to the Clinic: Brochure Download

    Bringing Cell Therapies to the Clinic: Brochure Download

    Despite the broad potential of RMP’s, clinical translation has been uneven. Barriers to broader adoption include regulatory uncertainty, paucity of clinically relevant data, the dynamic nature of modern cell science, less than-ethical “stem cell” marketing, non-standardized protocols, uncertain revenue models, and inadequate education and training of healthcare professionals and patients alike. As with many major advances in medicine – hematology, IVF, orthopedic surgery to name but a few – broad adoption of RMP’s will require clinical/ scientific leadership, protocol standardization, professional and patient education, and regulatory and third party payor acceptance. Regen Med — comprising internationally recognized clinical and thought leaders in regenerative medicine — is dedicated to assisting hospitals as well as smaller medical practices address these issues. Being product agnostic, Regen Med is able to align its interests with its “Affiliates” in establishing approaches to regenerative medicine which are evidence based, regulatorily-compliant and economically sensible.

    To read more, please download our full brochure: HCTCenter_Brochure_DIGITAL

  • HCT Centers: Frequently Asked Questions Download

    Human Cell/Tissue Centers (“HCT”) support the delivery of regenerative medicine procedures in a manner designed to obtain consistent clinical results. Whether as a large teaching hospital, or small, specific practice, an HCT center is a reliable, profitable and regulatorily compliant assets for the establishment of a regenerative medicine practice. To learn more about HCT Centers and gain answers to frequently asked questions by our affiliates, please click here.

  • Regen Med for Healthcare Professionals

    Regen Med supports hospitals, clinics and physicians around the world in the delivery of regulatorily-compliant and evidence-based regenerative medicine procedures (“RMP’s”). Together, the Company’s management, Clinical/Scientific Advisory Board, and affiliated thought-leaders provide many decades of international surgical, medical, scientific, financial, legal and business experience directly relevant to the application of regenerative medicine in a clinical setting. To learn more about how Regen Med works with Healthcare Professionals, download the full PDF here.

  • Save the Date: CELLS 2016

    Save the date for this year’s CELLS conference, to be held in Amsterdam, October 7-9.  Event to be hosted at the 5 Star NH Grand Hotel Krasnapolsky, located squarely in the city center of bustling Amsterdam. Stand by for additional conference details, including: clinically relevant conference program download, diverse speaker list announcement and a memorable gala dinner invitation.

  • Gold Winner: CELLS 2015 Abstract Submissions Contest

    Non-Reconstructable Peripheral Vascular Disease of the Lower Extremity in Ten Patients Treated With Adipose-derived Stromal Vascular Fraction Cells:  SVF cell therapy for end-stage disease
    Submitted by: Michael Carstens, M.D., Diego Correa, M.D., Ph.D., Arturo Gomez, M.D., Ronald Cortés, M.D., Elizabeth Turner, M.D., Cecilia Pérez, M.D., Marlon Ocon, M.D.